Plasma homocysteine as a risk factor for vascular disease: The European Concerted Action Project

Journal of the American Medical Association

Volumn 277, Issue 22, 1997, Pages 1775-1781

  Graham, Lan M ^a   Daly, Leslie E ^b   Refsum, Helga M ^b   Robinson, Killian ^b   Brattström, Lars E ^b   Ueland, Per M ^b   Palma Reis, Roberto J ^b   Boers, Godfried H J ^b   Sheahan, Richard G ^b   Lsraelsson, Bo ^b   Uiterwaal, Cuno S ^b   Meleady, Raymond ^b   McMaster, Dorothy ^b   Verhoef, Petra ^b   Witteman, Jacqueline ^b   Rubba, Paolo ^b   Bellet, Hélène ^b   Wautrecht, Jan C ^c   De Valk, Harold W ^d   Sales Lúis, Armando C ^b   Parrot Roulaud, Françoise M ^e   Tan, Kok Soon ^f   Higgins, Isabella ^b   Garcon, Danielle ^g   Medrano, Maria José ^h   Candito, Mirande ⁱ   Evans, Alun E ^b   Andria, Generoso ^b   more..

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

^b University Libre de Bruxelles ^*

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e HÔPITAL PELLEGRIN   (France)

^f CHANGI GENERAL HOSPITAL   (Singapore)

^g AIX MARSEILLE UNIVERSITY   (France)

^h CARLOS III INSTITUTE OF HEALTH   (Spain)

ⁱ PASTEUR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXAL 5 PHOSPHATE;

ADULT; AMINO ACID ANALYSIS; ARTICLE; ATHEROSCLEROSIS; BRAIN ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; VASCULAR DISEASE;

EID: 1842331509     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.277.22.1775     Document Type: Article

References (38)

1. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA. 1995;274:1049-1057.
2. Ueland PM, Refsum H, Brattström L. Plasma homocysteine and vascular disease. In: Francis RB Jr, ed. Atherosclerotic Cardiovascular Disease, Hemostasis and Endothelial Function. New York, NY: Marcel Dekker Inc; 1992:183-236.
3. Graham IM. Homocysteine as a risk factor for cardiovascular disease. Trends Cardiovasc Med. 1991;1:244-249.
4. McCully KS, Wilson RB. Homocysteine theory of arteriosclerosis. Atherosclerosis. 1975;22:215-227.
5. McCully KS. Homocysteine theory of arteriosclerosis: development and current status. Atheroscler Rev. 1983;11:157-246.
6. Malinow MR, Nieto FJ, Szklo M, Chambless LE, Bond G. Carotid artery intimal-medial wall thickening and plasma homocysteine in asymptomatic adults: the Atherosclerosis Risk in Communities Study. Circulation. 1993;87:1107-1113.
7. Mayer E, Miller D, Gupta A, et al. High homocysteine concentrations: an independent risk factor for coronary atherosclerosis in women. J Am Coll Cardiol. 1995;25:390A. Abstract 802-5.
8. Sheahan R, Graham I, Refsum H, et al. Women with coronary artery disease: lower folate and higher homocysteine. Eur Heart J. 1994;15:530.
9. Mudd SH, Levy HL, Skovby F. Disorders of transsulphuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. 6th ed. New York, NY: McGraw Hill International Book Co; 1989;1:693-734.
10. Cooper BA, Rosenblatt DS. Inherited defects of vitamin B12 metabolism. Annu Rev Nutr. 1987; 7:291-320.
11. Rosenblatt DS, Cooper BA. Inherited disorders of vitamin B12 utilization. Bioessays. 1990;12: 231-334.
12. Ubbink JB, Vermaals WJH, van der Merwe A, Becker PJ. Vitamin B-12, vitamin B-6 and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr. 1993;57:47-53.
13. Landgren F, Israelsson B, Lindgren A, Hultberg B, Andersson A, Brattström L. Plasma homocysteine in acute myocardial infarction: homocysteine-lowering effect of folic acid. J Intern Med. 1995;237:381-388.
14. Brattström L, Lindgren A, Israelsson B, Andersson A, Hultberg B. Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med. 1994;236:633-641.
15. Witteman JCM, Uiterwaal C. Study design to examine interactions between heterozygous homocystinuria and other risk factors for vascular disease. In: Robinson K, ed. Homocysteinemia and Vascular Disease: Proceedings of an EC Comac-Epidemiology Expert Group Workshop. Luxembourg, Belgium: Commission of the European Communities; 1990:119-130. Report No. EUR12834 EN.
16. Graham I. Homocysteinemia and Vascular Disease: Annual Report for 1989-90: Methodology and Protocol for an International Case-Control Study. Luxembourg, Belgium: Commission of the European Communities; 1992. Report No. EUR 13927 EN.
17. Lindgren A, Brattström L, Norrving B, Hultberg B, Andersson A, Johansson B. Plasma homocysteine in the acute and convalescent phases after stroke. Stroke. 1995;26:795-800.
18. Boers G. Refinement of the methionine loading test. In: Robinson K, ed. Homocysteinemia and Vascular Disease: Proceedings of an EC Comac-Epidemiology Expert Group Workshop. Luxembourg, Belgium: Commission of the European Communities; 1990:61-66.
19. Refsum H, Ueland PM, Svardal AM. Fully automated fluorescence assay for determining total homocysteine in plasma. Clin Chem. 1989;35:1921-1927.
20. Rothman KJ. Modern Epidemiology. Boston, Mass: Little Brown & Co; 1986.
21. Lee J. An insight on the use of multiple logistic regression analysis to estimate association between risk factor and disease occurrence. Int J Epidemiol. 1986;15:22-29.
22. Silberberg JA. Estimating the benefits of cholesterol lowering: are risk factors for coronary heart disease multiplicative? J Clin Epidemiol. 1990;43: 875-879.
23. SAS Institute Inc. SAS Technical Report P-229 SAS/STAT Software: Changes and Enhancements, Version 6.07. Gary, NC: SAS Institute Inc; 1992.
24. Brattström L, Israelsson B, Norrving B, et al. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease: effects of pyridoxine and folic acid treatment. Atherosclerosis. 1990;81:51-60.
25. Brattström L, Israelsson B, Hultberg B. Plasma homocysteine and methionine tolerance in early-onset vascular disease. Haemostasis. 1989;19(suppl 1):35-44.
26. Bostom AG, Jacques PF, Nadeau MR, Williams RR, Ellison RC, Selhub J. Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: initial results from the NHLBI family heart study. Atherosclerosis. 1995;116:147-151.
27. Stampfer MJ, Malinow MR, Willett WC, et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA. 1992;268:877-881.
28. Taylor LM, DeFrang RD, Harris EJ, Porter JM. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease. J Vasc Surg. 1991;13:128-136.
29. Arnesen E, Refsum H, Bonaa K, Ueland PM, Forde OH, Nordrehaug JE. Serum total homocysteine and coronary heart disease. Int J Epidemiol. 1995;24:704-709.
30. Selhub J, Jacques PF, Bostom AG, et al. Association between plasma homocysteine concentrations and extracranial carotid artery stenosis. N Engl J Med. 1995;332:286-291.
31. Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG. Prospective study of serum total homoeysteine concentration and risk of stroke in middle-aged British men. Lancet. 1995; 346:1395-1398.
32. Verhoef P, Hennekens CH, Malinow MR, Kok FJ, Willett WC, Stampfer MJ. A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke. 1994;25:1924-1930.
33. Alfthan G, Pekkanen J, Jauhianen M, et al. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis. 1994;106:9-19.
34. Pancharuniti N, Lewis CA, Sanberlich HE, et al. Plasma homocysteine, folate and vitamin B-12 concentrations and risk for early onset coronary artery disease. Am J Clin Nutr. 1994;59:940-948.
35. Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg I. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 1993;270:2693-2698.
36. Olszewski AJ, McCully K. Homocysteine metabolism and the oxidative modification of proteins and lipids. Free Radic Biol Med. 1993;14:683-693.
37. Parthasarathy S. Oxidation of low density lipoproteins by thiol compounds leads to its recognition by the acetyl LDL receptor. Biochim Biophys Acta. 1987;917:337-340.
38. Nygard O, Vollset SE, Refsum H, et al. Total plasma homocysteine and cardiovascular risk profile: the Hordaland Homocysteine Study. JAMA. 1995;274:1526-1533.